aap acquires rights on Adcon® from Wright Medical Technologies

(PresseBox) ( Berlin, )
aap Implantate AG, a leading European Bio-Implants company acquires WMT´s products to inhibit post-surgical scarring and adhesions following lumbar surgery named Adcon® L with immediate effect. Included are all intellectual property, name and distribution rights.

aap´s Dutch subsidiary EMCM acted based on its innovative Hydrogel technology as producer of Adcon® L already before signing the agreement. Together with this product, successfully launched in a lot of countries already, aap takes over an established network of international distribution partners.

aap intends to achieve an FDA registration and to develop under the brand Adcon® a broader product portfolio in the sector of adhesion control (prevention of organic tissue adhesion) within the coming years.

For 2008 aap expects a revenue with Adcon® products of approx. EUR 1.5 million and a positive contribution margin to its results.
The publisher indicated in each case is solely responsible for the press releases above, the event or job offer displayed, and the image and sound material used (see company info when clicking on image/message title or company info right column). As a rule, the publisher is also the author of the press releases and the attached image, sound and information material.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to service@pressebox.de.